Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Laura Meleady"'
Autor:
Laura Meleady, Morgan Towriss, Jennifer Kim, Vince Bacarac, Vivien Dang, Megan E. Rowland, Annie Vogel Ciernia
Publikováno v:
Epigenetics, Vol 18, Iss 1 (2023)
As the primary innate immune cells of the brain, microglia respond to damage and disease through pro-inflammatory release of cytokines and neuroinflammatory molecules. Histone acetylation is an activating transcriptional mark that regulates inflammat
Externí odkaz:
https://doaj.org/article/8fe789b251584367a744896fbae211dd
Publikováno v:
JGH Open, Vol 4, Iss 3, Pp 446-453 (2020)
Background and Aim While weight gain during infliximab therapy in inflammatory bowel disease (IBD) is common, there has been limited research evaluating its impact on infliximab efficacy. Methods Primary aims of this study were to determine the frequ
Externí odkaz:
https://doaj.org/article/b2f0267748aa432bb20ace2d98efe5d2
Autor:
Adi Eindor-Abarbanel, Laura Meleady, Sally Lawrence, Zachary Hamilton, Gena Krikler, Alam Lakhani, Qian Zhang, Kevan Jacobson
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 75:473-479
Limited data are currently available regarding anti-tumor necrosis factor (TNF) use and outcomes in very early onset inflammatory bowel disease (VEOIBD) patients. We aimed to assess the long-term outcomes and time to progression to anti-TNF treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b12692f252e7201f8b368242657cf6d
https://doi.org/10.1097/mpg.0000000000003551
https://doi.org/10.1097/mpg.0000000000003551
Autor:
Laura Meleady, Morgan Towriss, Jennifer Kim, Vince Bacarac, Megan Rowland, Annie Vogel Ciernia
BackgroundAs the primary innate immune cells of the brain microglia respond to damage and disease through pro-inflammatory release of cytokines and neuroinflammatory molecules. Histone acetylation is an activating transcriptional mark that regulates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e2a0f50241c695446d5854a5fa84265
https://doi.org/10.1101/2022.09.08.507183
https://doi.org/10.1101/2022.09.08.507183
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 4:207-209
Background Early onset inflammatory bowel disease (EOIBD) and Very early onset inflammatory bowel disease (VEOIBD) prevalence has been increasing over the last decades. These young patients have been known to have special disease characteristics and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5a2acad4d1c29b45f0069e866287283
https://doi.org/10.1093/jcag/gwab002.189
https://doi.org/10.1093/jcag/gwab002.189
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open, Vol 4, Iss 3, Pp 446-453 (2020)
JGH Open, Vol 4, Iss 3, Pp 446-453 (2020)
Background and Aim While weight gain during infliximab therapy in inflammatory bowel disease (IBD) is common, there has been limited research evaluating its impact on infliximab efficacy. Methods Primary aims of this study were to determine the frequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b74cd83229fdaf5ca58d58c3f6d9b09
http://europepmc.org/articles/PMC7273726
http://europepmc.org/articles/PMC7273726
Publikováno v:
Paediatr Child Health
Introduction/Background Asthma education and action plans have been shown to improve compliance and symptom control. Provincial guidelines, created in 2015, included asthma action plans, but use of these resources across our site was not consistent.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bff2bf669348b0e5a1a424a847510e0
https://europepmc.org/articles/PMC7437247/
https://europepmc.org/articles/PMC7437247/
Background Magnetic Resonance (MR) Imaging is the preferred imaging method in Inflammatory Bowel Disease (IBD) patients to investigate for small bowel disease. There are challenges in performing MR imaging in Early Onset IBD (EO-IBD) patients, and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d4e20221ee0ca1d61fe1accefb56e1
https://europepmc.org/articles/PMC7043422/
https://europepmc.org/articles/PMC7043422/